About CeQur
CeQur is a company based in Horw (Switzerland) founded in 2008.. CeQur has raised $391.6 million across 5 funding rounds from investors including Tandem Diabetes, Credit Suisse and Schroders. CeQur offers products and services including CeQur Simplicity Patch. CeQur operates in a competitive market with competitors including scPharmaceuticals, Crossject, Valeritas, Vaxxas and Incline Therapeutics, among others.
- Headquarter Horw, Switzerland
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cequr Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$391.6 M (USD)
in 5 rounds
-
Latest Funding Round
$120 M (USD), Series D
Jan 07, 2025
-
Investors
Tandem Diabetes
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CeQur
CeQur offers a comprehensive portfolio of products and services, including CeQur Simplicity Patch. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Wearable patch for injection-free insulin delivery and glucose management.
Funding Insights of CeQur
CeQur has successfully raised a total of $391.6M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $120 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series D — $120.0M
-
First Round
First Round
(05 Jan 2010)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2025 | Amount | Series D - CeQur | Valuation |
investors |
|
| Apr, 2021 | Amount | Series C - CeQur | Valuation | Credit Suisse , Endeavour Vision | |
| Sep, 2015 | Amount | Series C - CeQur | Valuation | Woodford Investment Management , Arthurian Life Sciences |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CeQur
CeQur has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Tandem Diabetes, Credit Suisse and Schroders. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Endeavour Vision is focused on transformative healthcare technology investments.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital is invested in US and Europe.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CeQur
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CeQur
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cequr Comparisons
Competitors of CeQur
CeQur operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as scPharmaceuticals, Crossject, Valeritas, Vaxxas and Incline Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure
|
|
| domain | founded_year | HQ Location |
Needle-free self-injectable drugs
|
|
| domain | founded_year | HQ Location |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| domain | founded_year | HQ Location |
Developer of vaccines to treat cancer and infectious diseases
|
|
| domain | founded_year | HQ Location |
Hospital-focused specialty pharmaceuticals are developed for acute pain management.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cequr
Frequently Asked Questions about CeQur
When was CeQur founded?
CeQur was founded in 2008 and raised its 1st funding round 2 years after it was founded.
Where is CeQur located?
CeQur is headquartered in Horw, Switzerland. It is registered at Horw, Luzern, Switzerland.
Who is the current CEO of CeQur?
Bradley Paddock is the current CEO of CeQur.
Is CeQur a funded company?
CeQur is a funded company, having raised a total of $391.6M across 5 funding rounds to date. The company's 1st funding round was a Series C of $100M, raised on Jan 05, 2010.
What does CeQur do?
CeQur was founded in 2008 and is headquartered in Horw, Switzerland. Operations focus on the medical device sector, particularly diabetes management solutions. The CeQur Simplicity device, a 3-day wearable patch, is designed to deliver rapid-acting insulin subcutaneously via a built-in cannula. This enables injection-free administration of mealtime boluses under the skin for users requiring insulin therapy.
Who are the top competitors of CeQur?
CeQur's top competitors include scPharmaceuticals, Crossject and Vaxxas.
What products or services does CeQur offer?
CeQur offers CeQur Simplicity Patch.
Who are CeQur's investors?
CeQur has 9 investors. Key investors include Tandem Diabetes, Credit Suisse, Schroders, Ypsomed, and Woodford Investment Management.